Sanofi (NYSE : SNY)
today announced that its US Consumer Healthcare Division, Chattem, Inc.,
completed the acquisition of the worldwide rights to the Rolaids^® brand from
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Loading...
Loading...
JNJJohnson & Johnson
$156.010.29%
Edge Rankings
Momentum
56.00
Growth
47.96
Quality
14.95
Value
25.10
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.